AptarGroup Inc (NYSE:ATR), a company specializing in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions, recently saw a significant insider transaction.
AptarGroup (ATR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Silgan's (SLGN) first-quarter top and bottom lines reflect the impacts of lower volumes owing to customer destocking.